Business Description
Rua Bioscience Ltd
ISIN : NZRUAE0004S1
Share Class Description:
NZSE:RUA: Ordinary SharesTotal Employee Number:
13Compare
Compare
Traded in other countries / regions
RUA.New Zealand IPO Date
2020-10-22Description
Rua Bioscience Ltd is a pharmaceutical company engaged in the production of cannabinoid medicines. The company caters to both domestic and international customers. It operates in one segment, being research and development and the sale of pharmaceutical products in Australia, Germany, and New Zealand.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.2 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | -0.65 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -5.68 | |||||
Beneish M-Score | 7.77 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 25 | |||||
3-Year EPS without NRI Growth Rate | 27.1 | |||||
3-Year FCF Growth Rate | 28.5 | |||||
3-Year Book Growth Rate | -46.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 84.55 | |||||
9-Day RSI | 75.17 | |||||
14-Day RSI | 71.5 | |||||
3-1 Month Momentum % | -6.67 | |||||
6-1 Month Momentum % | -20 | |||||
12-1 Month Momentum % | -38.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.58 | |||||
Quick Ratio | 1.33 | |||||
Cash Ratio | 0.77 | |||||
Days Inventory | 123.42 | |||||
Days Sales Outstanding | 95.53 | |||||
Days Payable | 191.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.4 | |||||
Shareholder Yield % | -28.86 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.38 | |||||
Operating Margin % | -187.73 | |||||
Net Margin % | -160.25 | |||||
EBITDA Margin % | -128.73 | |||||
FCF Margin % | -106.74 | |||||
OCF Margin % | -106.74 | |||||
ROE % | -60.82 | |||||
ROA % | -44.58 | |||||
ROIC % | -65.12 | |||||
3-Year ROIIC % | -23.75 | |||||
ROC (Joel Greenblatt) % | -92.31 | |||||
ROCE % | -55.5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 4.55 | |||||
PB Ratio | 2.42 | |||||
Price-to-Tangible-Book | 4.1 | |||||
EV-to-EBIT | -4.27 | |||||
EV-to-EBITDA | -4.87 | |||||
EV-to-Revenue | 6.29 | |||||
EV-to-FCF | -5.44 | |||||
Earnings Yield (Greenblatt) % | -23.48 | |||||
FCF Yield % | -16.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rua Bioscience Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NZ$) | 2.151 | ||
| EPS (TTM) (NZ$) | -0.015 | ||
| Beta | 1.0351 | ||
| 3-Year Sharpe Ratio | -0.53 | ||
| 3-Year Sortino Ratio | -0.78 | ||
| Volatility % | 76.14 | ||
| 14-Day RSI | 71.5 | ||
| 14-Day ATR (NZ$) | 0.001265 | ||
| 20-Day SMA (NZ$) | 0.03545 | ||
| 12-1 Month Momentum % | -38.79 | ||
| 52-Week Range (NZ$) | 0.026 - 0.057419 | ||
| Shares Outstanding (Mil) | 338.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rua Bioscience Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rua Bioscience Ltd Stock Events
| Event | Date | Price (NZ$) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-10-28 15:00 | In 88 days | ||
| Annual report for 2026 | 2026-09-29 | In 58 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-31 | In 29 days | ||
| Second quarter earnings results for 2026 | 2026-02-27 | 0.03 (+0.00%) | ||
| General meeting for 2025 | 2025-10-28 15:00 | 0.03 (+0.00%) | ||
| Annual report for 2025 | 2025-09-29 | 0.04 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2025-08-31 | 0.06 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-02-27 | 0.03 (+0.00%) | ||
| General meeting for 2024 | 2024-11-04 10:00 | 0.04 (+0.00%) | ||
| Annual report for 2024 | 2024-09-30 | 0.03 (+0.00%) |
Show
Entries
Rua Bioscience Ltd Frequently Asked Questions
What is Rua Bioscience Ltd(NZSE:RUA)'s stock price today?
The current price of NZSE:RUA is NZ$0.04. The 52 week high of NZSE:RUA is NZ$0.06 and 52 week low is NZ$0.03.
When is next earnings date of Rua Bioscience Ltd(NZSE:RUA)?
The next earnings date of Rua Bioscience Ltd(NZSE:RUA) is 2026-08-31 Est..
Does Rua Bioscience Ltd(NZSE:RUA) pay dividends? If so, how much?
Rua Bioscience Ltd(NZSE:RUA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Rua Bioscience Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers